**Core tip:** Mode of delivery may influence the immune system of offspring with possible long-term consequences. We report a case of twins one of which delivered vaginally while the other delivered by caesarian section (C-section). We found lower frequency of immune cells in the cord blood and placenta of C-section delivered compared to vaginally delivered newborn. However, higher percentage of neutrophils was observed in the placenta of C-section delivered newborn. Interestingly, for the very first time we found lower percentages of immunosuppressive CD71^+^ erythroid cells in both cord blood and placenta tissues of C-section delivered offspring. Thus, mode of delivery can modulate the immune system of newborn. In particular, lower frequency of CD71^+^ erythroid cells and its potential impact on adaptation to microbiome merits further investigations.

INTRODUCTION
============

Pregnancy is a fascinating biological and immunological phenomenon that not only impacts the health of the growing infant but also influences its future wellbeing. A significant body of literature has suggested that the method of delivery at the end of this journey can influence the future health of the infant\[[@B1]\]. Vaginal delivery is commonly performed but in complicated or high-risk pregnancies delivery is performed by caesarian sections (C-sections). According to a report by World Health Organization (WHO) in 2013, 32.7% of births were achieved by C-section in the United States of America, which demonstrates a significant demand for this procedure\[[@B2]\]. This trend is reflected in many parts of the world such as China (approximately 50%), in some parts of Brazil (80%)\[[@B1]\] and appears to be on the rise globally\[[@B3],[@B4]\]. Despite the fact that C-section is integral for the safety of the mother and the newborn in some cases, maternal demand or recommendation by physicians for this procedure has increased world-wide without the consideration of potential long-term impacts on the growing newborn. Many studies suggest that C-section may come at a price for the offspring. The initial establishment of the neonatal microbiome is mainly determined by maternal-newborn exchanges of microbiota. During the normal vaginal delivery, the infant is exposed to a myriad of commensal bacteria, which colonize the urogenital tract of the mother\[[@B5]\]. C-section delivery appears to be the greatest insult to the natural congregation of the neonatal microbiome\[[@B6]\]. Upon exposure to these commensal bacteria, the infant's immune system becomes educated, and through these interactions gets trained to tolerate non-harmful and non-self-antigens\[[@B7]\]. Thus, vaginal delivery and exposure to maternal microbiota *via* breastfeeding are evolutionary important to the newborn's development and health. Furthermore, continued exposure to environmental microbiota is considered to be essential for the development of the microbiome and subsequently the immune system of the offspring as suggested by the hygiene hypothesis\[[@B8]\]. Together these studies elude to the growing body of work that describes how clinically intervened delivery methods may impact the immune system and overall health of the newborn.

The mechanisms which contribute to immune system training are diverse and can be complicated; however, disrupting the mother-to-child transmission of microbiota by C-sections may result in increased risk of asthma, celiac disease, obesity and autoimmune diseases such as type 1 diabetics\[[@B9]-[@B11]\].

For instance, a study conducted on monozygotic (MZ) twins at different ages demonstrated that MZ twins' immune systems became increasingly divergent at later ages suggesting immunological variations stem primarily from the environmental and non-heritable factors\[[@B12]\]. Although initial microbial interactions and mother-to-offspring microbiota exchanges are crucial in the development of neonatal microbiome and immune system education, immediate effects of delivery methods on the neonatal immune system is not very well studied.

Several studies have reported differences in cord blood biomarkers in C-section *vs* vaginal deliveries\[[@B11]-[@B13]\]. However, we are unaware of any study showing the possible impact of delivery mode on cord blood and placenta immunological biomarkers in twins born to an inflammatory bowel disease (IBD) mothers.

Recently, we have reported that CD71^+^ erythroid cells co-expressing CD71 (transferrin receptor) and CD235 (erythroid lineage marker) are physiologically abundant in human cord blood and placenta tissues\[[@B13],[@B14]\]. These cells have distinctive immunosuppressive properties and quench excessive inflammation induced by abrupt commensal colonization in the newborn\[[@B14]\]. In addition, we have shown that CD71^+^ erythroid cells expand during pregnancy and play an important role in feto-maternal tolerance\[[@B13]\]. A more recent study reported lower frequency of CD71^+^ erythroid cells in pre-term deliveries\[[@B15]\] however their frequency and function in vaginal *vs* C-section deliveries of full-term pregnancies in particular in IBD patients' needs to be determined.

Here a delivery of twins by a mother with ulcerative colitis is reported. In this study, we analyzed the delivery effects on immune biomarkers in cord blood, placental tissues and fecal samples 12 wk postpartum. Particular attention was made on the frequency of CD71^+^ erythroid cells with immunomodulatory activities\[[@B13],[@B14],[@B16]-[@B18]\].

MATERIALS AND METHODS
=====================

Case description
----------------

Twin A was born by naturally induced vaginal delivery, the other twin by urgent C-section which is commonly practiced in order to reduce stress for the second twins\[[@B19]\] or due to delivery associated complications. In this case, the head of baby B was high and variable uncomplicated fetal heart rate decelerations was noted. As the head was descending the cervix did clamp down, at that point urgent C-section was recommended. Child A was born at 21:45 and child B by C-section at 22:22 pm, 37 min apart.

Samples collection
------------------

Cord blood and placental tissues were collected at the time of delivery from an ulcerative colitis patient participating in an IBD related study. Fecal samples from twins were collected 12 wk later. The patient was human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) seronegative.

Cell isolation
--------------

Immune cells from cord blood mononuclear cells (CBMCs) were isolated by Ficoll-paque gradient separation on premium Ficoll-paque (GE). Placental immune cells were isolated from the extravillous placental tissues followed by Ficoll-paque gradient separation according to our previous report\[[@B13]\]. CD71^+^ erythroid cells were isolated and enriched as we have previously reported elsewhere\[[@B14],[@B16]\]. Purity of enriched CD71^+^ erythroid cells was ≥ 96% for subsequent experiments.

Flow cytometry
--------------

Antibodies used for this study were purchased from BD bioscience or eBioscience: anti-CD3 (SK7), anti-CD4 (RPA-T4), anti-CD8 (SK1), anti-CD14 (M5E2), anti-CD16 (3G8), anti-CD71 (HB15e), anti-CD235a (GA-R2), anti-program death-1 (PD-1) (EH12.1), anti-lymphocyte-activation gene 3 (LAG-3) (3DS223H), and anti-T-cell immunoglobulin and mucin-domain containing-3 (TIM-3) (F38-2E2). Cell viability was measured using LIVE/DEAD Aqua (Life Technologies).

Fecal calprotectin measurement
------------------------------

Fecal samples were collected from newborns at 12 wk of age and kept frozen until use. The frozen fecal samples were thawed and a CALEX Cap Stool Extraction Device (Bühlmann Laboratories, AG) was used to dilute the samples to a working concentration. The fecal calprotectin (FCP) was measured using a fCAL ELISA Calprotectin kit (Bühlmann Laboratories, AG).

Gene expression analysis
------------------------

Total RNA was isolated from enriched CD71^+^ erythroid cells in TRIzol (Sigma) using the RNeasy Mini Kit (Qiagen). The purified RNA was quantified on NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies) and 1 μg RNA of each sample was reverse-transcribed using QuantiTect Reverse Transcription kit (Qiagen). The analysis of mRNA expression level was performed on CFX96 Touch^TM^ Real-Time PCR Detection System (BioRad) using TaqMan Fast Advanced Master Mix (Applied Biosystems) with TaqMan probes for arginase-2 (Hs00982833-m1), transforming growth factor beta-1 (TGF-β1) (Hs00998133-m1), vascular endothelial growth factor A (VEGFα) (Hs00900055-m1) and the phagocyte NADPH oxidase (NOX2) (QT00029533). Actin (QT00088935) was used as a reference gene, and the gene expression of the targeted genes was calculated by the 2^-ΔΔCt^ method.

Ethical considerations
----------------------

All patient samples and information were collected according to the Institutional Review Boards at the University of Alberta. The study participant provided written consent to participate in this study.

RESULTS
=======

Clinical observations of the mother, infants at delivery and 12 wk of age
-------------------------------------------------------------------------

The mother had ulcerative colitis and on Sulfasalazine during pregnancy with clinical history outlined in Table [1](#T1){ref-type="table"}. The twins were born at gestational age of 37 wk with different APGAR scores and weight at birth (Table [2](#T2){ref-type="table"}). Follow ups indicated that both twins were healthy, gained weight in similar trend and breastfed until 12 wk of age.

###### 

The mother's clinical history during pregnancy

  **Age (yr)**           **Diagnosis**        **Disease phenotype**   **Daily medications**   **FCP Score at third trimester**   **Objective CRP**   **pMayo Score**   **Clinical remission**
  ---------------------- -------------------- ----------------------- ----------------------- ---------------------------------- ------------------- ----------------- ------------------------
  34                     Ulcerative colitis   E3 pancolitis           Sulfasalazine (2 g)     176.41 μg/mL                       11.5                1                 Yes
  Omeprazole (20 mg)                                                                                                                                                   
  Prenatal vitamin (1)                                                                                                                                                 

FCP: Fecal calprotectin; CRP: C reaction protein.

###### 

Twins clinical data

                         **Vaginally delivered twin**   **Urgent C-section**
  ---------------------- ------------------------------ ----------------------
  Gestational age (wk)   37                             37
  Sex of the baby        Female                         Male
  Birthweight (g)        2720                           3150
  APGAR Score            9, 9, 9, 9                     1, 8, 9
  FCP (12 wk of age)     40.89                          982

C-section: Caesarean section; FCP: Fecal calprotectin.

Immunophenotyping of cord blood cells
-------------------------------------

Immune phenotyping was performed for the frequency of different immune cells such as T cells, natural killer (NK) cells, monocytes, CD71^+^ erythroid cells and neutrophils. Cell populations were gated according to the gating strategies (Figure [1A](#F1){ref-type="fig"}). We observed a trend in higher abundance of immune cells (*e.g*. T cells, monocytes and neutrophils) in the vaginally delivered newborn in comparison to the C-section delivered (Figure [1B](#F1){ref-type="fig"} and C), which in consistent with other reports\[[@B20],[@B21]\]. Following these observations, the expression of immune checkpoint molecules (PD-1, LAG-3 and TIM-3) were measured on the surface of CD4^+^ and CD8^+^ T cells. A slight increase in (PD-1/Tim-3) expression was noted on the CD4^+^ T cells from the infant delivered by C-section compared to the naturally delivered newborn, while the expression of other inhibitory molecules remained constant (Figure [1D](#F1){ref-type="fig"} and E). Interestingly, the expression of inhibitory molecules TIM-3 and PD-1 were much higher on CD8^+^ T cells compared to CD4^+^ T cells but no difference was observed between the twins (Figure [1F](#F1){ref-type="fig"} and G). Although the functionality of T cells was not investigated in this study, these findings suggest that CD4^+^ and CD8^+^ T cells may function differently in cord blood due to different expression pattern of inhibitory receptors.

![Immunophenotyping of cord blood cells. A: Showing flow cytometry gating strategy for different immune cells in cord blood. B: Representative dot plots showing T cells (CD3, CD4 and CD8), monocytes (CD14 and CD16) and NK cells (CD56 and CD16) in cord blood of vaginally or C-section delivered newborns. C: Cumulative data showing percentages of different immune cells in cord blood. D: Representative dot plots showing expression of PD-1/LAG-3 and PD-1/TIM-3 on CD4^+^ T cells. E: Percentages of PD-1, LAG-3 and TIM-3 on CD4^+^ T cells from cord blood of twins. F: Representative dot plots showing expression of PD-1/LAG-3 and PD-1/TIM-3 on CD8^+^ T cells. G: Percentages of PD-1, LAG-3 and TIM-3 on CD8^+^ T cells from cord blood of twins. H: Representative dot plots showing percentages of CD71^+^CD235^+^ cells in cord blood of vaginally *vs* C-section delivered twins. I: qPCR data showing fold gene expression for TGF-β, NOX2, arginase-2, VISTA and VEGFα in enriched CD71^+^ erythroid cells from cord blood. NK: Natural killer; C-section: Caesarean section; PD-1: Program death-1; LAG-3: Lymphocyte-activation gene 3; TIM-3: T-cell immunoglobulin and mucin-domain containing-3; qPCR: Quantitative polymerase chain reaction; TGF-β: Transforming growth factor beta; NOX-2: The phagocyte NADPH oxidase; VISTA: V-domain Ig suppressor of T cell activation; VEGFα: Vascular endothelial growth factor A.](WJG-24-4787-g001){#F1}

CD71^+^ erythroid suppressor cells have been shown to play an integral role in feto-maternal tolerance and neonatal immunity\[[@B13],[@B14],[@B16]-[@B18]\]. Thus, we measured their frequency in cord blood and interestingly observed higher frequency of CD71^+^ erythroid cell in the cord blood of the offspring born by vaginal route compared to C-section delivered newborn (Figure [1H](#F1){ref-type="fig"}). Higher frequency of CD71^+^ erythroid cells due to their immunosuppressive nature may create a more immunosuppressive milieu in the cord blood of vaginally delivered newborn. This is reflected by a trend in higher expression of inhibitory receptors on CD4^+^ T cells in C-section delivered cord blood. Inhibitory receptors can be considered as activation markers in an acute setting but in chronic conditions these receptors are associated with T cell exhaustion\[[@B22],[@B23]\]. Furthermore, we analyzed the expression of some genes \[TGF-β, NOX2, arginase-2, V-domain Ig suppressor of T cell activation (VISTA) and VEGFα\] associated with immunological properties of CD71^+^ erythroid cells as we have described elsewhere\[[@B13],[@B14],[@B16]\]. Interestingly, we observed higher expression of TGF-β and arginase-2 mRNA however lower expression of NOX2 mRNA in CD71^+^ erythroid cells isolated from the cord blood of C-section compared to the vaginally delivered newborn (Figure [1I](#F1){ref-type="fig"}). However, the mRNA expression for VISTA and VEGFα remained similar in CD71^+^ erythroid cells obtained from the cord blood of both newborns (Figure [1I](#F1){ref-type="fig"}).

Immunophenotyping of placental cells
------------------------------------

Placental immune cells were analyzed using flow cytometry by the gating strategies detailed in Figure [2A](#F2){ref-type="fig"} for different immune cells (*e.g*., T cells, NK cells, neutrophils, monocytes and CD71^+^ erythroid cells). No difference in the frequency of T cells and NK cells was observed (Figure [2B](#F2){ref-type="fig"} and C) however we found a substantial increase in CD14^+^ CD16^-^ monocytes (6.28% compared to 2%) and neutrophils (21.9% compared to 8.69%) in the placental tissues of the infant born by C-section compared to the vaginally delivered newborn (Figure [2A](#F2){ref-type="fig"}-C). Upon further analysis, we found that CD4^+^ T cells from the placenta of the C-section delivered child had higher expression of TIM-3 and PD-1 (Figure [2D](#F2){ref-type="fig"} and E). In consistent with cord blood data, higher expression of TIM-3 on placental CD8^+^ *vs* CD4^+^ T cells was observed without any difference between the twins (Figure [2F](#F2){ref-type="fig"} and G).

![Immunophenotyping of placental cells. A: Showing flow cytometry gating strategy for different immune cells in placenta. B: Representative dot plots showing T cells (CD3, CD4 and CD8), monocytes (CD14 and CD16) and NK cells (CD56 and CD16) in placenta of vaginally or C-section delivered newborns. C: Cumulative data showing percentages of different immune cells in placenta. D: Representative dot plots showing expression of PD-1/LAG-3 and PD-1/TIM-3 on CD4^+^ T cells. E: Percentages of PD-1, LAG-3 and TIM-3 on CD4^+^ T cells from placental tissues of twins. F: Representative dot plots showing expression of PD-1/LAG-3 and PD-1/TIM-3 on CD8^+^ T cells. G: Percentages of PD-1, LAG-3 and TIM-3 on CD8^+^ T cells from placental tissues of twins. H: Representative dot plots showing percentages of CD71^+^CD235^+^ cells in placental tissues of vaginally *vs* C-section delivered twins. I: Data showing levels of FCP in fecal samples of twins as measured by ELISA. NK: Natural killer; C-section: Caesarean section; PD-1: Program death-1; LAG-3: Lymphocyte-activation gene 3; TIM-3: T-cell immunoglobulin and mucin-domain containing-3; FCP: Fecal calprotectin; ELISA: Enzyme-linked immuno sorbent assay.](WJG-24-4787-g002){#F2}

More interestingly, we observed almost 50% reduction in the abundance of CD71^+^ erythroid cells in the placental tissues of the infant born by C-section compared to her naturally delivered brother (Figure [2H](#F2){ref-type="fig"}). Therefore, lower frequency of CD71^+^ erythroid cells may explain more inflammatory response in C-section child reflected by higher monocytes and neutrophils presence (Figure [2A](#F2){ref-type="fig"} and C).

Early implications of C-section delivery
----------------------------------------

To investigate the potential impact of C-section on the newborns' intestinal health, we analyzed the abundance of FCP in the fecal samples of both newborns at 12 wk of age. We found that the amount of FCP was substantially elevated in the fecal sample of the infant born by C-section, indicating increased intestinal inflammation (Figure [2I](#F2){ref-type="fig"}).

DISCUSSION
==========

Mode of delivery is critical in shaping the immune system of the offspring. Existing evidence support immunological differences in newborns delivered by C-section *vs* vaginal deliveries\[[@B21],[@B24]\]. In this report, we have investigated immunological differences in cord blood and placenta of twins one delivered by vaginal and the other by urgent C-section. A trend in reduction of T cells, monocytes and neutrophils was observed in the cord blood of C-section delivered *vs* the vaginally delivered twin. This is in line with other reports indicating that C-section newborns have lower leukocytes count in their cord blood\[[@B20]\]. Similarly, lower percentages of neutrophils, NK cells and monocytes in the cord blood are reported for C-section deliveries\[[@B25],[@B26]\] however we did not observe any difference in frequency of NK cells in this report. There is no report about the possible changes in the frequency of CD71^+^ erythroid cells in cord blood of C-section *vs* vaginal deliveries. Of note, we found that the C-section twin had 10% lower CD71^+^ erythroid cells in cord blood *vs* his sister who was delivered by vaginal route. Strikingly, we observed 3-fold higher percentages of monocytes (2.03% to 6.48%) and neutrophils (9% to 22%) in C-section delivered *vs* vaginal delivered placental tissues. In contrast, we found 50% lower percentages of CD71^+^ erythroid cells in placental tissues of C-section delivered twin. CD71^+^ erythroid cells have distinctive immunosuppressive properties as we have reported elsewhere\[[@B13],[@B14],[@B16]\]. Therefore, higher expression of inhibitory receptors (PD-1 and TIM-3) on CD4^+^ T cells in cord blood and placental tissues of C-section delivered newborn suggest the presence of a pro-inflammatory milieu. This is reflected by the presence of more neutrophils and monocytes in the placental tissues of the C-section delivered twin. The most striking observation was that the C-section delivered newborn had \> 20-fold FCP in his fecal sample compared to the vaginally delivered sister at 12 wk of age. Of note, FCP can be normally higher in healthy breast-fed compared to formula-fed infants\[[@B27]\], however both twins in this study were breastfed until the time of sample collection.

Of note, we have shown that CD71^+^ erythroid cells prevent improper immune activation against commensal microbial colonization in neonates\[[@B14]\], therefore lower frequency of CD71^+^ erythroid cells in C-section deliveries may impair swift adaptation to microbiota and predisposes these newborns to a more pro-inflammatory response in their gut.

Although, existing data suggest that C-section delivery alters bacterial exchange between mother-newborn with long term immunological subsequences, our observations indicate immediate immunological differences at the feto-maternal interface in twins delivered by different delivery modes. It was very interesting to see that CD71^+^ erythroid cells had different profiles in terms of mRNA expression for genes associated with their immunomodulatory properties. Therefore, our observations suggest that the stress associated with the mode of delivery or any complications during delivery can have substantial effects on both the mother's and the newborn's immune systems. In our case the child B was delivered 37 min later than child A and therefore, delay in delivery as a confounding factor should be taken in consideration.

As for the clinical significance of our finding, mode of delivery not only can have long-term consequences (microbiome development) for the child but also short-term immunological effects should be taken in consideration. Although, we are unable to dissociate the possible impact of delay in the delivery of the second twin's due to urgent C-section, our observations merit further examinations.

In IBD patients, decision-making around delivery is more complex than the general population because of medications (*e.g*. immunosuppressive use), wound healing, anatomical considerations such as previous surgeries, rectal and perianal disease\[[@B28]\]. In the meantime, decision making between the providers and IBD patients is crucial especially considering the potential long-term impact of delivery mode in the newborn's future wellbeing.

A higher awareness among childbearing mothers and professional about the association of elective C-section and adverse immunological effects is warranted. Thus, both short- and long-term consequences of delivery modes appear to be greater than what is considered nowadays.

In conclusion, our study provides another piece of evidence on how route of delivery can influence the newborn's immune system. In particular, for the very first time we have shown that mode of delivery impacts the frequency and functionality of CD71^+^ erythroid cells in cord blood and placenta tissues. Our findings suggest mode of delivery directs immunological changes which may have potential long-term effects on the offspring. Future research should focus on different modes of delivery in twins especially longitudinal aspects targeting immunological functions.

ARTICLE HIGHLIGHTS
==================

Research background
-------------------

The delivery mode may impact newborn's immune system with possible short-term and long-term consequences. Several studies suggest that caesarian section (C-section) may come at a price for the newborn. C-section delivery prevents the exposure of newborn to the mother's microbiome in the birth canal. Whereas vaginal delivery and exposure to maternal microbiota *via* breastfeeding are evolutionary important to the newborn's development and health. However, the impacts of mode of delivery in twins is not fully understood.

Research motivation
-------------------

Disrupting the mother-to-child transmission of microbiota by C-sections may result in increased risk of asthma, celiac disease, obesity and autoimmune diseases. Thus, investigating the impact of delivery mode on newborns immune system development is crucial for protecting this highly fragile population.

Research objectives
-------------------

We investigated whether delivery mode by C-section compared to vaginal delivery in twins can influence the immunological components of their cord blood and placenta. In addition, our aim was to determine if C-section delivery impacts the frequency of CD71^+^ erythroid cells in cord blood and placenta tissues.

Research methods
----------------

We performed immune cells isolation from fresh cord blood and placenta tissues. Then, immunophenotyping was performed for different immune cell subsets in cord blood and placenta of twins. Finally, CD71^+^ erythroid cells were isolated for RNA isolation and quantitative polymerase chain reaction PCR (qPCR) analysis.

Research results
----------------

Our results indicated lower frequency of immune cells in cord blood of C-section delivered newborn compared to the vaginally delivered newborn. In contrast, we observed higher percentages of monocytes and neutrophils in placenta tissues of C-section delivered newborns and higher expression of inhibitory receptors on T cells. More importantly, we found lower frequency of CD71^+^ erythroid cells in both cord blood and placenta of C-section delivered newborn compared to the vaginally delivered newborn. Interestingly, CD71^+^ erythroid cells from C-section delivered newborn had a different gene profile compared to the vaginally delivered one.

Research conclusions
--------------------

Our study provides another piece of evidence that delivery mode can influence the newborn's immune system. In particular, we have investigated this in a case of twins one delivered by C-section while the other by vaginal route. We have shown for the very first time that mode of delivery impacts the frequency and functionality of CD71^+^ erythroid cells in cord blood and placenta tissues. Our findings suggest mode of delivery may result in immunological changes with possible long-term effects on the offspring.

Research perspectives
---------------------

C-section delivery may negatively impact neonatal immune system. Our study is a clear example indicating immunological differences in cord blood and placenta tissues of twins. Further longitudinal studies are required to investigate potential short-term and long-term impacts of C-section *vs* vaginally delivery in twins.
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